Global Facial Aesthetics Market Overview:
According to SPER Market Research, the Global Facial Aesthetics Market is estimated to reach USD 31.04 billion by 2032 with a CAGR of 15.72%.
A non-invasive aesthetic process called facial aesthetics is used to treat skin issues such scars, acne, hyperpigmentation, wrinkles, dark skin, and stretch marks. Various facial aesthetic procedures, including microdermabrasion, chemical peels, dermal fillers, botulinum toxin, and cosmetic implants, are used to enhance aesthetic appeal. Dermal fillers used in facial cosmetic operations include hyaluronic acid, calcium hydroxyapatite, poly-L-lactic acid, and polymethyl-methacrylate microspheres. The rise in female population, the number of key players offering various facial aesthetic products, the number of procedures performed on the face, the number of products that key players have approved, and the number of procedures performed on the face all contribute to the growth of the global facial aesthetics market.
Impact of COVID-19 on the Global Facial Aesthetics Market
It is projected that the COVID-19 epidemic will negatively affect the development of the global face aesthetics market. To boost hospital capacity for COVID-19 patients, a number of clinics and hospitals were reorganized. Surgery that wasn't absolutely necessary was postponed because of the pandemic. The non-emergency nature of facial aesthetics procedures severely limited the earnings of aesthetic businesses. Additionally, it is projected that the market for facial aesthetics will be negatively impacted by the sudden abrupt fall in people’s monthly income.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Product, By Application, By End User. |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | Candela Syneron, Evolus Inc, Sinclair Pharmaceuticals Limited, Abbvie Inc, Anika Therapeutics, Bausch Health Companies Inc, Cutera Inc, Cynosure, Fotona D.O.O, Galderma Laboratories, Ipsen, Johnsons & Johnsons, Merz Pharma, Revance Therapeutics, Teoxane.
|
Global Facial Aesthetics Market Segmentation:
By Product: Based on the Product, Global Facial Aesthetics Market is segmented as; Dermal Fillers (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-lactic Acid, Polymethyl- methacrylate Microspheres, Others), Botulinum Toxin, Microdermabrasion, Chemical Peels, Others.
By Application: Based on the Application, Global Facial Aesthetics Market is segmented as; Facial Line Correction Treatment, Scar Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others.
By End User: Based on the End User, Global Facial Aesthetics Market is segmented as; Specialty & Dermatology Clinics, Hospitals, Others.
By Region: North America owns the high share of this request; the major factors of the request's growth in the region are the adding prevalence of habitual ails, the growing quantum of drug conventions brought on by the region's fleetly growing population, and the expansion of crucial request actors in the area.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Facial Aesthetics Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Facial Aesthetics Market, By Product, 2019-2032 (USD Million)
6.1. Dermal Fillers
6.1.1. Hyaluronic Acid
6.1.2. Calcium Hydroxyapatite
6.1.3. Poly-L-lactic Acid
6.1.4. Polymethyl- methacrylate Microspheres
6.1.5. Others
6.2. Botulinum Toxin
6.3. Microdermabrasion
6.4. Chemical Peels
6.5. Others
7. Global Facial Aesthetics Market, By Application, 2019-2032 (USD Million)
7.1. Facial Line Correction Treatment
7.2. Scar Treatment
7.3. Lip Enhancement
7.4. Restoration of Volume/Fullness
7.5. Others
8. Global Facial Aesthetics Market, By End User, 2019-2032 (USD Million)
8.1 Specialty & Dermatology Clinics
8.2 Hospitals
8.3 Others
9. Global Facial Aesthetics Market, By Region, 2019-2032 (USD Million)
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 South Korea
9.3.6 Rest of Asia-Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of South America
9.5 Middle East & Africa
9.5.1 Kingdom of Saudi Arabia
9.5.2 United Arab Emirates
9.5.3 Rest of Middle East & Africa
10. Company Profiles
10.1. Candela Syneron
10.1.1 Company details
10.1.2 Financial outlook
10.1.3 Product summary
10.1.4 Recent developments
10.2. Evolus Inc
10.2.1 Company details
10.2.2 Financial outlook
10.2.3 Product summary
10.2.4 Recent developments
10.3. Sinclair Pharmaceuticals Limited
10.3.1 Company details
10.3.2 Financial outlook
10.3.3 Product summary
10.3.4 Recent developments
10.4. Abbvie Inc
10.4.1 Company details
10.4.2 Financial outlook
10.4.3 Product summary
10.4.4 Recent developments
10.5. Anika Therapeutics
10.5.1 Company details
10.5.2 Financial outlook
10.5.3 Product summary
10.5.4 Recent developments
10.6. Bausch Health Companies Inc
10.6.1 Company details
10.6.2 Financial outlook
10.6.3 Product summary
10.6.4 Recent developments
10.7. Cutera Inc
10.7.1 Company details
10.7.2 Financial outlook
10.7.3 Product summary
10.7.4 Recent developments
10.8. Cynosure
10.8.1 Company details
10.8.2 Financial outlook
10.8.3 Product summary
10.8.4 Recent developments
10.9. Fotona D.O.O
10.9.1 Company details
10.9.2 Financial outlook
10.9.3 Product summary
10.9.4 Recent developments
10.10. Galderma Laboratories
10.10.1 Company details
10.10.2 Financial outlook
10.10.3 Product summary
10.10.4 Recent developments
10.11. Ipsen
10.11.1 Company details
10.11.2 Financial outlook
10.11.3 Product summary
10.11.4 Recent developments
10.12. Johnson and Johnson
10.12.1 Company details
10.12.2 Financial outlook
10.12.3 Product summary
10.12.4 Recent developments
10.13. Merz Pharma
10.13.1 Company details
10.13.2 Financial outlook
10.13.3 Product summary
10.13.4 Recent developments
10.14. Revance Therapeutics.
10.14.1 Company details
10.14.2 Financial outlook
10.14.3 Product summary
10.14.4 Recent developments
10.15. Teoxane
10.15.1 Company details
10.15.2 Financial outlook
10.15.3 Product summary
10.15.4 Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
